169 related articles for article (PubMed ID: 36338967)
1. Identification of DAPK1 as an autophagy-related biomarker for myotonic dystrophy type 1.
Hu M; Ge MR; Li HX; Zhang B; Li G
Front Genet; 2022; 13():1022640. PubMed ID: 36338967
[TBL] [Abstract][Full Text] [Related]
2. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
4. Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model.
Bargiela A; Cerro-Herreros E; Fernandez-Costa JM; Vilchez JJ; Llamusi B; Artero R
Dis Model Mech; 2015 Jul; 8(7):679-90. PubMed ID: 26092529
[TBL] [Abstract][Full Text] [Related]
5. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
6. MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway.
Song KY; Guo XM; Wang HQ; Zhang L; Huang SY; Huo YC; Zhang G; Feng JZ; Zhang RR; Ma Y; Hu QZ; Qin XY
Cell Death Dis; 2020 Jul; 11(7):545. PubMed ID: 32683410
[TBL] [Abstract][Full Text] [Related]
7. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
8. HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1.
O'Leary DA; Vargas L; Sharif O; Garcia ME; Sigal YJ; Chow SK; Schmedt C; Caldwell JS; Brinker A; Engels IH
Curr Chem Genomics; 2010 Mar; 4():9-18. PubMed ID: 20502647
[TBL] [Abstract][Full Text] [Related]
9. Metabolic complications in myotonic dystrophy type 1: A cross-sectional survey using the National Registry of Japan.
Hama M; Horie R; Kubota T; Matsumura T; Kimura E; Nakamura H; Takahashi MP; Takada H
J Neurol Sci; 2021 Aug; 427():117511. PubMed ID: 34082146
[TBL] [Abstract][Full Text] [Related]
10. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of GSK3β-Target Proteins in Skin Fibroblasts of Myotonic Dystrophy Type 1 (DM1) Patients.
Grande V; Hathazi D; O'Connor E; Marteau T; Schara-Schmidt U; Hentschel A; Gourdon G; Nikolenko N; Lochmüller H; Roos A
J Neuromuscul Dis; 2021; 8(4):603-619. PubMed ID: 33682722
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
[TBL] [Abstract][Full Text] [Related]
13. Fourier-Transform Infrared Spectroscopy as a Discriminatory Tool for Myotonic Dystrophy Type 1 Metabolism: A Pilot Study.
Mateus T; Almeida I; Costa A; Viegas D; Magalhães S; Martins F; Herdeiro MT; da Cruz E Silva OAB; Fraga C; Alves I; Nunes A; Rebelo S
Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33917301
[TBL] [Abstract][Full Text] [Related]
14. Overview of the Complex Relationship between Epigenetics Markers, CTG Repeat Instability and Symptoms in Myotonic Dystrophy Type 1.
de Pontual L; Tomé S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408837
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin.
Mateus T; Martins F; Nunes A; Herdeiro MT; Rebelo S
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33673200
[TBL] [Abstract][Full Text] [Related]
16. Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.
Morales F; Corrales E; Zhang B; Vásquez M; Santamaría-Ulloa C; Quesada H; Sirito M; Estecio MR; Monckton DG; Krahe R
Hum Mol Genet; 2021 Dec; 31(2):262-274. PubMed ID: 34432028
[TBL] [Abstract][Full Text] [Related]
17. Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1.
Itoh K; Mitani M; Kawamoto K; Futamura N; Funakawa I; Jinnai K; Fushiki S
Acta Histochem Cytochem; 2010 Dec; 43(6):149-56. PubMed ID: 21245981
[TBL] [Abstract][Full Text] [Related]
18. Myotonic Dystrophy Type 1 Clinical, Electrophysiological and Molecular Characterization: Experience at Tertiary Care Centre.
Khadilkar S; Jagiasi K; Yadav J; Chavan SV; Soni G; Patel B
J Assoc Physicians India; 2017 Jun; 65(6):32-37. PubMed ID: 28782311
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1.
Ausems CRM; Raaijmakers RHL; van den Broek WJAA; Willemse M; van Engelen BGM; Wansink DG; van Bokhoven H
Mol Ther Methods Clin Dev; 2019 Dec; 15():120-132. PubMed ID: 31649961
[TBL] [Abstract][Full Text] [Related]
20. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
